CAR-T Therapy

CAR-T therapy engineers T cells to attack cancer; focus on auto/allo and targets.The sector's total market cap is 1554.28 billion USD, with a 24h change of +0.76%. Among 7 constituents, 7 are up (100.00%) and 0 are down (0%). The top gainer is GSK plc American Depositary Shares (Each representing two Ordinary Shares) (GSK), with a 24h increase of +1.20%.CAR-T steady; breadth mixed. Favor leaders; be selective.
Name
Last Price
Change %
Last Price / Change %
Chart
Price Range
Action
JNJ
JNJJohnson & Johnson
266.01$269.95
+0.98%
+1.48%
AH
266.01
+0.98%
$264.75$268.36
AMGN
AMGNAmgen Inc
376.09$377.00
+0.01%
+0.24%
AH
376.09
+0.01%
$376.08$381.60
PFE
PFEPfizer Inc.
24.67$24.68
+0.48%
+0.04%
AH
24.67
+0.48%
$24.62$24.84
GILD
GILDGilead Sciences Inc
130.49$130.58
+0.89%
+0.06%
AH
130.49
+0.89%
$130.49$132.51
GSK
GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares)
51.97$51.98
+1.20%
+0.01%
AH
51.97
+1.20%
$51.90$52.47
INCY
INCYIncyte Genomics Inc
118.93$118.00
+1.07%
-0.78%
AH
118.93
+1.07%
$118.93$120.00
NVS
NVSNovartis AG
156.11$156.11
+0.71%
0.00%
AH
156.11
+0.71%
$156.11$157.59